Works matching IS 10781552 AND DT 2021 AND VI 27 AND IP 6
Results: 34
Comment on biotin-induced thyroid stimulating hormone aberrations in the setting of immunotherapy.
- Published in:
- 2021
- By:
- Publication type:
- Letter
The nivolumab/cabozantinib combination and the future of doublets in advanced renal cell cancer treatment.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Updates in the management of relapsed/refractory multiple myeloma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 6, p. 1477, doi. 10.1177/10781552211028906
- By:
- Publication type:
- Article
Reduced emergency room visits and improved medication adherence of an integrated oncology pharmaceutical care practice in China.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 6, p. 1503, doi. 10.1177/10781552211027218
- By:
- Publication type:
- Article
Novel targets for refractory kidney cancer: Where are we heading?
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 6, p. 1559, doi. 10.1177/10781552211027216
- By:
- Publication type:
- Article
The growing importance of biomonitoring studies in professionals occupationally exposed to antineoplastic drugs: Conceptions, guidelines and critical questions.
- Published in:
- 2021
- By:
- Publication type:
- Letter to the Editor
Difficulties in biomonitoration of occupational exposure to antineoplastic drugs.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 6, p. 1557, doi. 10.1177/10781552211026368
- By:
- Publication type:
- Article
Can biosimilar products be interchangeable? Pharmaceutical perspective in the implementation of biosimilars in oncology.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 6, p. 1491, doi. 10.1177/10781552211016099
- By:
- Publication type:
- Article
Does systemic anti-tumor therapy increase COVID-19 risk in patients with cancer?
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 6, p. 1461, doi. 10.1177/10781552211015762
- By:
- Publication type:
- Article
Treatment outcomes among human epidermal growth factor receptor 2 positive breast cancer patients: A systematic review.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 6, p. 1468, doi. 10.1177/10781552211005530
- By:
- Publication type:
- Article
Gemcitabine-induced dilated-cardiomyopathy in patient with platinum-refractory ovarian-cancer: A case report and literature review.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 6, p. 1542, doi. 10.1177/1078155220982044
- By:
- Publication type:
- Article
Delayed immune thrombocytopenia after discontinuation of nivolumab therapy: A case report and literature review.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 6, p. 1548, doi. 10.1177/1078155220981155
- By:
- Publication type:
- Article
Acute cytokine release syndrome after a first dose of pembrolizumab as second-line treatment for metastatic, programmed death-ligand 1-positive, non-small-cell lung cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 6, p. 1528, doi. 10.1177/1078155220980813
- By:
- Publication type:
- Article
Recurrent and reversible bilateral palmar blue discoloration following administration of liposomal daunorubicin-cytarabine (Vyxeos®) for acute myeloid leukemia with myelodysplasia-related changes.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 6, p. 1539, doi. 10.1177/1078155220978452
- By:
- Publication type:
- Article
Nivolumab for the salvage treatment of desperate germ cell tumor: A case report.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 6, p. 1516, doi. 10.1177/1078155220977638
- By:
- Publication type:
- Article
Late-onset double-seronegative myasthenia gravis syndrome and myasthenic crisis due to nivolumab use for Hodgkin's lymphoma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 6, p. 1534, doi. 10.1177/1078155220976797
- By:
- Publication type:
- Article
Delayed presentation of doxorubicin extravasation into pleural space: Case report and review of literature.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 6, p. 1520, doi. 10.1177/1078155220975848
- By:
- Publication type:
- Article
Drug-related problems in head and neck cancer patients identified by repeated medication reviews on consecutive therapy cycles.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 6, p. 1439, doi. 10.1177/1078155220962178
- By:
- Publication type:
- Article
Enhancing patients' understanding of and adherence to oral anticancer medication: Results of a longitudinal pilot intervention.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 6, p. 1409, doi. 10.1177/1078155220960800
- By:
- Publication type:
- Article
Leveraging advanced preparation of oncology medications: Decreasing turnaround-times in an outpatient infusion center.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 6, p. 1454, doi. 10.1177/1078155220960222
- By:
- Publication type:
- Article
Does nutritional status affect treatment tolarability, response and survival in metastatic colorectal cancer patients? Results of a prospective multicenter study.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 6, p. 1357, doi. 10.1177/1078155220959427
- By:
- Publication type:
- Article
Initial tacrolimus weight-based dosing strategy in allogeneic hematopoietic stem-cell transplantation.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 6, p. 1447, doi. 10.1177/1078155220959416
- By:
- Publication type:
- Article
Development of a simple compatibility inspection method using pressure in a BD PhaSeal™ system and hazardous drug vials.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 6, p. 1321, doi. 10.1177/1078155220952518
- By:
- Publication type:
- Article
Involvement of C677T MTHFR variant but not A1298C in methotrexate-induced toxicity in acute lymphoblastic leukemia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 6, p. 1382, doi. 10.1177/1078155220951898
- By:
- Publication type:
- Article
Evaluation of the efficacy of a self-cleaning automated compounding system for the decontamination of cytotoxic drugs.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 6, p. 1343, doi. 10.1177/1078155220951866
- By:
- Publication type:
- Article
Real-world intensive safety monitoring of biosimilars rituximab and trastuzumab in a Portuguese oncology hospital.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 6, p. 1432, doi. 10.1177/1078155220957079
- By:
- Publication type:
- Article
Anti-drug antibodies anti-trastuzumab in the treatment of breast cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 6, p. 1354, doi. 10.1177/1078155220953873
- By:
- Publication type:
- Article
Outcomes with enoxaparin dose reductions during thrombocytopenia in patients with hematopoietic stem cell transplantation (HSCT).
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 6, p. 1364, doi. 10.1177/1078155220957747
- By:
- Publication type:
- Article
Cyto-SAT: A self-assessment tool for the safe handling of cytotoxic drugs adapted for use in low- and middle-income countries.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 6, p. 1422, doi. 10.1177/1078155220956687
- By:
- Publication type:
- Article
Awareness is the first step: What Ghanaian community pharmacists know about cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 6, p. 1333, doi. 10.1177/1078155220955211
- By:
- Publication type:
- Article
Evaluating genomic biomarkers associated with resistance or sensitivity to chemotherapy in patients with advanced breast and colorectal cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 6, p. 1371, doi. 10.1177/1078155220951845
- By:
- Publication type:
- Article
Is the duration of castration resistance predictive for sequential treatment responses in the metastatic castration-resistant prostate cancer setting?
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 6, p. 1388, doi. 10.1177/1078155220951612
- By:
- Publication type:
- Article
Long term stability of an admixture of alizapride and ondansetron in 0.9% sodium chloride solution polyolefin bags stored at 5±3°C.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 6, p. 1328, doi. 10.1177/1078155220950442
- By:
- Publication type:
- Article
Permeation measurement of 27 chemotherapy drugs after simulated dynamic testing on 15 surgical and examination gloves: A knowledge update.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 6, p. 1395, doi. 10.1177/1078155220950423
- By:
- Publication type:
- Article